Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients

Epilepsy and Behavior

Volumn 12, Issue 1, 2008, Pages 102-108

  Park, Sung Pa ^a   Hwang, Yang Ha ^a   Lee, Ho Won ^a   Suh, Chung Kyu ^a   Kwon, Soon Hak ^a   Lee, Byung In ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Adverse effects; Cognition; Epilepsy; Mood; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; ZONISAMIDE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; ATTENTION DISTURBANCE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EEG ABNORMALITY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MEMORY DISORDER; MONOTHERAPY; MOOD CHANGE; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; TASK PERFORMANCE; WORD RECOGNITION;

ADOLESCENT; ADULT; AFFECT; ANTICONVULSANTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; ISOXAZOLES; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 37049006335     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2007.08.002     Document Type: Article

References (38)

1. Motamedi G., and Meador K. Epilepsy and cognition. Epilepsy Behav 4 Suppl. 2 (2003) S25-S38
2. Aldenkamp A.P., Krom M.D., and Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 44 Suppl. 4 (2003) S21-S29
3. Ortinski P., and Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 5 Suppl. 1 (2004) S60-S65
4. Masuda Y., Ishizaki M., and Shimizu M. Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Rev 4 (1998) 341-360
5. Leppik I.E. Zonisamide. Epilepsia 40 Suppl. 5 (1999) S23-S29
6. Oommen K.J., and Mathews S. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 22 (1999) 192-200
7. Leppik I.E., Willmore L., Homan R., et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 14 (1993) 165-173
8. Tosches W.A., and Tisdell J. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide. Epilepsy Behav 8 (2006) 522-526
9. Ohtahara S., and Yamatogi Y. Erratum to "Safety of zonisamide therapy: prospective follow-up survey". Seizure 16 (2007) 87-93
10. Wilfong A.A. Zonisamide monotherapy for epilepsy in children and young adults. Pediatr Neurol 32 (2005) 77-80
11. Kothare S.V., Kaleyias J., Mostofi N., et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol 34 (2006) 351-354
12. Brodie M.J. Zonisamide as adjunctive therapy for refractory partial seizures. Epilepsy Res 68 Suppl. 2 (2006) S11-S16
13. Leppik I.E. Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Res 68 Suppl. 2 (2006) S17-S24
14. Newmark M.E., and Dubinsky S. Zonisamide monotherapy in a multi-group clinic. Seizure 13 (2004) 223-225
15. Berent S., Sackellares J.C., Giordani B., Wagner J.G., Donofrio P.D., and Abou-Khalil B. Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 28 (1987) 61-67
16. Wilensky A.J., Friel P.N., Ojemann L.M., Dodrill C.B., McCormick K.B., and Levy R.H. Zonisamide in epilepsy: a pilot study. Epilepsia 26 (1985) 212-220
17. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
18. Lutz M.T., and Helmstaedter C. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy. Epilepsy Behav 7 (2005) 708-714
19. Williams J.M. Memory Assessment Scales professional manual (1991), Psychological Assessment Resources, Odessa, FL
20. Wechsler D. Wechsler Memory Scale-Revised manual (1987), Psychological Corp., San Antonio, TX
21. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: theory and clinical interpretation. 2nd ed. (1993), Neuropsychology Press, Tucson, AZ
22. Goodglass H, Kaplan E, Barresi B. Boston Diagnostic Aphasia Examination-Third Edition (BDAE-3). San Antonio, TX: Psychological Corp.; 2000.
23. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erlbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 53-63
24. Beck A.T., and Steer R.A. Manual for the Beck Anxiety Inventory (1990), Psychological Corp., San Antonio, TX
25. Kockelmann E., Elger C.E., and Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 54 (2003) 171-178
26. Piazzini A., Canevini M.P., Maggiori G., and Canger R. The perception of memory failures in patients with epilepsy. Eur J Neurol 8 (2001) 613-620
27. Akaho R. The effects of antiepileptic drugs on cognition in normal volunteers. Psychiatry Clin Neurosci 50 (1996) 61-69
28. Yamauchi T., and Aikawa H. Efficacy of zonisamide: our experience. Seizure 13 Suppl. 1 (2004) S41-S48
29. Sills G.J., and Brodie M.J. Pharmacokinetics and drug interactions with zonisamide. Epilepsia 48 (2007) 435-441
30. Lee H.W., Jung D.K., Suh C.K., Kwon S.H., and Park S.P. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up. Epilepsy Behav 8 (2006) 736-741
31. Goodman L., and Gilman A. The pharmacological basis of therapeutics (1941), Macmillan, New York p. 1029-31
32. Dodrill C.B. Effects of sulthiame upon intellectual, neuropsychological, and social functioning abilities among adult epileptics: comparison with diphenylhydantoin. Epilepsia 16 (1975) 617-625
33. Ueda Y., Doi T., Tokumaru J., and Willmore L.J. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Brain Res Mol Brain Res 116 (2003) 1-6
34. Petroff O.A., Hyder F., Rothman D.L., and Mattson R.H. Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42 (2001) 543-548
35. Aldenkamp A.P., and Bodde N. Behaviour, cognition and epilepsy. Acta Neurol Scand 112 Suppl. 182 (2005) S19-S25
36. Berto P. Quality of life in patients with epilepsy and impact of treatments. Pharmacoeconomics 20 (2002) 1039-1059
37. Ketter T.A., Post R.M., and Theodore W.H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 53 Suppl. 2 (1999) S53-S67
38. McElroy S.L., Suppes T., Keck Jr. P.E., et al. Open-label adjunctive zonisamide in the treatment of bipolar disorder: a prospective trial. J Clin Psychiatry 66 (2005) 617-624